M-A: Study shows significant risk of major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism.
14 Sep, 2021 | 08:55h | UTCLong-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Long-term Anticoagulation After Unprovoked VTE: New Insights – TCTMD
Extended Anticoagulation Tied to Major Bleeding Risk – HealthDay
Commentary on Twitter
? Delighted to share the MAJESTIC Study providing best available estimates for major bleeding risk during extended #anticoagulation of up to 5 years in patients with unprovoked #VTE (& clinically important subgroups), now published in @AnnalsofIM!https://t.co/Ri2EvZvffq pic.twitter.com/3jvN8mTKSi
— Faizan Khan (@FaizanK91) September 13, 2021